scispace - formally typeset
N

Nicholas A. Peppas

Researcher at University of Texas at Austin

Publications -  840
Citations -  101193

Nicholas A. Peppas is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Self-healing hydrogels & Polymer. The author has an hindex of 141, co-authored 825 publications receiving 90533 citations. Previous affiliations of Nicholas A. Peppas include National Technical University & University of Texas System.

Papers
More filters
Journal ArticleDOI

Solute diffusion in swollen membranes. Part II. Influence of crosslinking on diffusive properties

TL;DR: In this paper, it was shown that the crosslinked structure of swollen polymers acts as a molecular screen for diffusion of large solutes, and it was concluded that the previously assumed linear dependence of the diffusion coefficient on the mesh size is not correct even for highly swollen membranes.
Book

Biomaterials: Interfacial Phenomena and Applications

TL;DR: Books, as a source that may involve the facts, opinion, literature, religion, and many others are the great friends to join with.
Journal ArticleDOI

Dynamic and equilibrium swelling behaviour of pH-sensitive hydrogels containing 2-hydroxyethyl methacrylate

TL;DR: It is shown that pH-sensitive behaviour with a wide range of swelling ratios could be obtained using a range of compositional changes and was a function of the acidity of the buffered solution.
Journal ArticleDOI

Solute and penetrant diffusion in swellable polymers. III. Drug release from glassy poly(HEMA-co-NVP) copolymers

TL;DR: In this article, the dynamic swelling behavior of poly(HEMA-co-NVP) copolymers at 37°C was investigated and it was observed that the swelling mechanism was non-Fickian, associated with major changes of the thickness and other dimensions of the samples.
Journal ArticleDOI

Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.

TL;DR: The data suggest that gels containing equimolar amounts of MAA:EG have the potential to be used as an oral carrier of peptide drugs, especially for insulin.